胃癌术前贫血治疗选择中的两难困境

Dilemma in selection of treatment for preoperative anemia in patients with gastric cancer

贫血是胃癌术前常见伴发症之一,并会对胃癌术后的短期恢复及预后产生不良影响,因此,术前贫血常常需要予以纠正.胃癌术前贫血治疗最常用的策略即输血,而目前大量证据表明输血会增加术后并发症及影响病人长期生存率.因此,胃癌术前贫血治疗中存在选择的两难困境,临床外科医师在管理此类病人时,如何平衡利弊,需要充分了解胃癌术前贫血治疗的两面性.本文对关于胃癌病人术前贫血及其治疗相关研究进行综述,对提高胃癌手术病人管理者的全局观提供参考.

One of the common comorbidities of patients with gastric cancer waiting for gastrectomy is anemia,which negatively affects the postoperative outcomes and prognosis.Therefore,preoperative anemia often needs to be corrected.The most commonly used strategy to treat preoperative anemia in gastric cancer is transfusion.Currently,a large amount of evidence shows that transfusion can increase the incidence of postoperative complications and affect the long-term survival of patients.Therefore,there is a dilemma in choosing the treatment for preoperative anemia in patients with gastric cancer.Surgeons need to fully understand the duality of therapy strategies for preoperative anemia in gastric cancer patients.In this study,we review the studies on preoperative anemia and its treatment in patients with gastric cancer,aiming to help clinicians manage patients undergoing gastrectomy for cancer better.